Choose date and time: ×
In the last 4 hours
In the last 8 hours
Better Buy: Celgene Corporation vs. Merck & Co. The Motley Fool22:06 17-Nov-18
Superbugs kill more in India than globally The Times of India20:23 17-Nov-18
FG earmarks N200M for Taraba Bio-Technology Centre Vanguard, Nigeria14:49 17-Nov-18
Why Abbvie Is Down 5% in 2018 So Far The Motley Fool13:44 17-Nov-18
In the last 7 days
Puma Biotechnology: Risky Investment Seeking Alpha23:07 16-Nov-18
Amgen Stock Is Cheap and Generates Loads of Cash Barron's Online15:44 16-Nov-18
A record-breaking year for biotech funding PharmaTimes13:30 16-Nov-18
United Therapeutics inks $1.2bn licensing deal with Arena Pharmaceutical Technology11:40 16-Nov-18
Drugmaker AbbVie donates $55M to 3 education nonprofits Belleville News-Democrat, Illinois11:15 16-Nov-18
Government incentives needed to tackle AMR European Pharmaceutical Manufacturer10:09 16-Nov-18
Boehringer and Epizyme enter US$300m deal European Biotechnology News06:37 16-Nov-18
Kovind stress on tech push for agro growth at NIT-Patna The Telegraph, Calcutta19:04 15-Nov-18
This Biotech Stock Is Flying On A $1.2 Billion Licensing Deal Investors Business Daily17:44 15-Nov-18
Migraine-Focused Biotech Has A Headache On Quarterly Losses Investors Business Daily17:44 15-Nov-18
Why uniQure N.V. Stock Is Skyrocketing Today The Motley Fool17:08 15-Nov-18
PharmaCord Names Patrick Lee Chief Financial Officer PR Newswire (Press Release)13:42 15-Nov-18
Why Is Amarin Corporation Stock Up 300% in 2018? The Motley Fool13:27 15-Nov-18

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!

Publication filters

Headline Density

  • We may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, please read our Privacy Policy and Cookie Policy, which also explains how you can control cookies. By clicking "OK" or continuing to use this site, you agree to allow such ads to be shown and cookies to be set.
Sorry, no headlines or news topics were found. Please try different keywords.